Chembio Diagnostics Inc (CEMI US) was rated new "Speculative Buy" at Benchmark by equity analyst Raymond Myers. The 12-month target price is $1.75 per share.
Ray Myers' # is 267-513-1752 (that's philly) and email@example.com He'll probably e-mail it to you.
Looks like the report came out a month ago on April 24th. Here is a link that references the coveragehttp://www.streetinsider.com/New+Coverage/Benchmark+Starts+Chembio+Diagnostics+%28CEMI%29+at+Speculative+Buy%3B+Potential+Over-the-Counter+HIV+Resting+Market/7366424.html
Sorry, no link I just have a copy of the report. Also have the latest Zacks report, very positive
He was on the call. I mentioned him on this board right after I heard his questions. He is REAL. Was at Emerging Growth Equities outside of Philly. Well thought of. Institutionally oriented as opposed to retail.This is the beginning.
He put out a fantastic 25 page report on the company.